Talis Biomedical Corporat...

AI Score

0

Unlock

1.68
-0.32 (-16.00%)
At close: Feb 28, 2025, 9:30 AM
0.00
-100.00%
After-hours: Dec 31, 1969, 07:00 PM EST

Talis Biomedical Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 412K 3.65M n/a 10.94M 3.98M 2.39M
Cost of Revenue 41K 8.39M 2.62M n/a n/a n/a
Gross Profit 371K -4.74M -2.62M 10.94M 3.98M 2.39M
Operating Income -66.81M -115.14M -191.82M -91.18M -26.7M -21.43M
Interest Income n/a n/a n/a 54K 42K 93K
Pretax Income -62.01M -113.01M -192.04M -91.13M -27.47M -21.34M
Net Income -62.01M -110.89M -190.46M -91.08M -27.43M -21.34M
Selling & General & Admin 28.21M 40.73M 42.42M 13.1M 6.86M 5.43M
Research & Development 40.69M 70.83M 157.59M 89.02M 23.81M 18.39M
Other Expenses -1.72M -1.16M -8.19M -10.94M -3.98M n/a
Operating Expenses 67.19M 110.4M 191.82M 91.18M 26.7M 21.43M
Interest Expense n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a
Cost & Expenses 67.23M 118.79M 191.82M 91.18M 26.7M 21.43M
Income Tax n/a -2.13M -1.58M -54K -42K 93K
Shares Outstanding (Basic) 1.82M 1.78M 1.51M 290K 150K 150.42K
Shares Outstanding (Diluted) 1.82M 1.78M 1.51M 290K 150K 150.42K
EPS (Basic) -34.12 -62.45 -126.13 -314.06 -182.88 -141.85
EPS (Diluted) -34.12 -62.45 -126.13 -314.06 -182.88 -141.85
EBITDA -66.05M -106.31M -191.82M -90.42M -25.97M -20.78M
Depreciation & Amortization 770K 11.6M 2.62M 1.37M 726K 647K